In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica
Leishmania aethiopica (L. aethiopica) is responsible for different forms of cutaneous leishmaniasis (CL) in Ethiopia. Treatment heavily depends on limited drugs, together with drawbacks like toxicity and microbia...
Source: BMC Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Markos Tadele, Solomon M. Abay, Peter Asaga, Eyasu Makonnen and Asrat Hailu Tags: Research Source Type: research
More News: Drugs & Pharmacology | Ethiopia Health | HIV-Leishmania Co-infection | Malaria | Toxicology